Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis

被引：0
|
作者：
Antoine Leuzy
Irina Savitcheva
Konstantinos Chiotis
Johan Lilja
Pia Andersen
Nenad Bogdanovic
Vesna Jelic
Agneta Nordberg
机构：
[1] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics Center for Alzheimer Research
[2] Karolinska University Hospital,Medical Radiation Physics and Nuclear Medicine
[3] Uppsala University,Department of Surgical Sciences, Radiology, Nuclear Medicine and PET
[4] Hermes Medical Solutions,Clinic for Cognitive Disorders, Theme Aging
[5] Karolinska University Hospital,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
[; F]Flutemetamol; Amyloid PET; Alzheimer’s disease; Diagnostic change; Cholinesterase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1276 / 1286
页数：10
相关论文
共 50 条
  • [31] Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
    Friederike Völter
    Leonie Beyer
    Florian Eckenweber
    Maximilian Scheifele
    Ngoc Bui
    Marianne Patt
    Henryk Barthel
    Sabrina Katzdobler
    Carla Palleis
    Nicolai Franzmeier
    Johannes Levin
    Robert Perneczky
    Boris-Stephan Rauchmann
    Osama Sabri
    Jimin Hong
    Paul Cumming
    Axel Rominger
    Kuangyu Shi
    Peter Bartenstein
    Matthias Brendel
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1384 - 1394
  • [32] Clinical impact of F-18 Flutemetamol (FMM) PET to assess cerebral Aβ pathology in patients with various cognitive disorders.
    Hattori, Naoya
    Ono, Shogo
    Udo, Niki
    Yamamoto, Shin
    Ogawa, Mikako
    Sugie, Hiroki
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [33] Spatial normalization of [18F] flutemetamol PET images utilizing an adaptive principal components template
    Lilja, Johan
    Leuzy, Antoine
    Chiotis, Konstantinos
    Savitcheva, Irina
    Sorensen, Jens
    Nordberg, Agneta
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [34] Optimization of Bayesian penalized likelihood reconstruction algorithm for [18F]flutemetamol amyloid PET images
    Fukuda, S.
    Miwa, K.
    Wagatsuma, K.
    Yakushiji, Y.
    Yamao, T.
    Kamitaka, Y.
    Nishikawa, N.
    Hasegawa, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S607 - S607
  • [35] Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases
    Lindstrom, Elin
    Oddstig, Jenny
    Danfors, Torsten
    Jogi, Jonas
    Hansson, Oskar
    Lubberink, Mark
    NEUROIMAGE-CLINICAL, 2020, 28
  • [36] Impact of [18F]FDG-PET and [18F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
    Christensen, Tine N.
    Langer, Seppo W.
    Persson, Gitte
    Larsen, Klaus Richter
    Amtoft, Annemarie G.
    Keller, Sune H.
    Kjaer, Andreas
    Fischer, Barbara Malene
    DIAGNOSTICS, 2021, 11 (02)
  • [37] Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET
    Antonini, A
    Kazumata, K
    Feigin, A
    Mandel, F
    Dhawan, V
    Margouleff, C
    Eidelberg, D
    MOVEMENT DISORDERS, 1998, 13 (02) : 268 - 274
  • [38] Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI
    Werner, P.
    Rullmann, M.
    Bresch, A.
    Tiepolt, S.
    Jochimsen, T.
    Lobsien, D.
    Schroeter, M. L.
    Sabri, O.
    Barthel, H.
    EJNMMI RESEARCH, 2016, 6
  • [39] Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI
    P. Werner
    M. Rullmann
    A. Bresch
    S. Tiepolt
    T. Jochimsen
    D. Lobsien
    M. L. Schroeter
    O. Sabri
    H. Barthel
    EJNMMI Research, 6
  • [40] [18F]FDG-PET/CT in patients with bacteremia: Clinical impact on patient management and outcome
    Hess, Soren
    FRONTIERS IN MEDICINE, 2023, 10
12345